Establishment Labs (NASDAQ:ESTA) Trading Up 10.1% – Here’s What Happened

Establishment Labs Holdings Inc. (NASDAQ:ESTA)’s share price traded up 10.1% during mid-day trading on Thursday . The stock traded as high as $33.51 and last traded at $33.21. 434,547 shares traded hands during trading, a decline of 33% from the average session volume of 644,690 shares. The stock had previously closed at $30.16.

Analyst Upgrades and Downgrades

Separately, Stephens raised shares of Establishment Labs to a “strong-buy” rating in a research note on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $60.60.

Establishment Labs Stock Up 11.4 %

The stock has a market capitalization of $940.52 million, a price-to-earnings ratio of -13.02 and a beta of 1.12. The business has a 50-day moving average of $39.19 and a 200-day moving average of $41.69. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62.

Institutional Trading of Establishment Labs

Several institutional investors have recently added to or reduced their stakes in ESTA. Rice Hall James & Associates LLC grew its stake in shares of Establishment Labs by 10.7% in the third quarter. Rice Hall James & Associates LLC now owns 793,300 shares of the company’s stock valued at $34,326,000 after buying an additional 76,959 shares in the last quarter. Kornitzer Capital Management Inc. KS increased its stake in Establishment Labs by 2.5% during the third quarter. Kornitzer Capital Management Inc. KS now owns 248,435 shares of the company’s stock worth $10,750,000 after purchasing an additional 6,050 shares during the period. Black Swift Group LLC acquired a new stake in shares of Establishment Labs during the third quarter worth about $312,000. Simplify Asset Management Inc. boosted its stake in shares of Establishment Labs by 67.7% in the third quarter. Simplify Asset Management Inc. now owns 21,639 shares of the company’s stock valued at $936,000 after purchasing an additional 8,732 shares during the period. Finally, Mudita Advisors LLP increased its stake in Establishment Labs by 19.0% during the 3rd quarter. Mudita Advisors LLP now owns 354,801 shares of the company’s stock worth $15,352,000 after buying an additional 56,700 shares during the period. Institutional investors and hedge funds own 72.91% of the company’s stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.